Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repurposing advanced DMEM/F-12 cell culture medium to mitigate glycerol toxicity in poultry semen.

British poultry science·2026
Same author

Lower FEV<sub>1</sub> and gram-negative bacilli isolation as independent risk factors for exacerbations in post-TB bronchiectasis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026
Same author

Seasonality in the incidence of acute sinusitis, air pollutant levels, and climate.

Rhinology·2025
Same author

Can bladder neck thickness on magnetic resonance imaging (MRI) predict early outcomes after anatomic enucleation of the prostate (AEEP) in benign prostatic hyperplasia patients with small-volume prostate?

Clinical radiology·2025
Same author

<i>ENAM</i> Mutations Can Cause Hypomaturation Amelogenesis Imperfecta.

Journal of dental research·2024
Same author

Regulation of epidermal growth factor receptor tyrosine kinase inhibitor resistance via Ambra1-mediated autophagy in non-small cell lung cancer.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2023

Related Experiment Video

Updated: Jun 15, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Comorbidities amongst patients with multiple sclerosis: a population-based controlled study.

J-H Kang1,2, Y-H Chen3, H-C Lin4

  • 1Department of Physical Medicine and Rehabilitation, Taipei Medical University Hospital, Taipei, Taiwan.

European Journal of Neurology
|March 3, 2010
PubMed
Summary
This summary is machine-generated.

Patients with multiple sclerosis (MS) have a higher risk of developing other medical conditions, including systemic lupus erythematosus and depression, compared to the general population. This study highlights the increased comorbidity burden in Chinese individuals with MS.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Related Experiment Videos

Last Updated: Jun 15, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Area of Science:

  • Neurology
  • Epidemiology
  • Public Health

Background:

  • Limited data exists on the comorbidity spectrum in multiple sclerosis (MS) patients, particularly within Asian populations.
  • Understanding these comorbidities is crucial for comprehensive patient care and resource allocation.

Purpose of the Study:

  • To investigate the prevalence and risks of various comorbidities in Chinese patients diagnosed with multiple sclerosis (MS).
  • To compare comorbidity patterns in MS patients against a matched control group.

Main Methods:

  • Utilized Taiwan's National Health Insurance Research Dataset to identify 898 MS patients and 4490 matched controls.
  • Analyzed 30 specific comorbid conditions using conditional logistic regression to assess risk differences between groups.

Main Results:

  • MS patients exhibited significantly higher risks for systemic lupus erythematosus (OR=26.9), depression (OR=6.9), and peripheral vascular disorders (OR=6.6).
  • Increased risks were also observed for deficiency anemias (OR=4.9), rheumatoid arthritis (OR=4.8), and fluid/electrolyte disorders (OR=4.8) in the MS cohort.

Conclusions:

  • Multiple sclerosis patients face a substantially elevated risk of developing multiple medical comorbidities.
  • This finding underscores the importance of screening for and managing comorbidities in ethnic Chinese individuals with MS.